According to ARRS’ American Journal of Roentgenology (AJR), the resources required to warm iohexol 350 to body temperature before injection for computed tomography (CT) may not be warranted, given the lack of observed practical benefit.

Values represent number of patients, with percentage in parentheses and 95% CI in brackets (not reported for levels of severity of allergic/allergic-like reactions). 95% CIs were calculated using the Clopper-Pearson exact formula. For events with zero frequency, one-sided 97.5% CIs are provided.


July 30, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), the resources required to warm iohexol 350 to body temperature before injection for computed tomography (CT) may not be warranted, given the lack of observed practical benefit.

“The data suggest that maintaining iohexol 350 at room temperature is non-inferior to warming the agent to body temperature before injection,” wrote first investigator Noor Basharat from the department of radiology at Valleywise Health in Phoenix, Ariz.

Although extrinsically warming iodinated CT contrast media to body temperature can reduce viscosity and injection pressures, clinical data examining its effect on adverse events are both limited and conflicting. Basharat and team’s retrospective study compared adult patients who received CT examinations using the low osmolality contrast media agent iohexol 350 (Omnipaque) that had either been warmed to body temperature or maintained at room temperature.

Among 3,939 patients (2,115 men, 1,824 women; median age, 48.0 years) who underwent CT using iohexol 350 prewarmed to body temperature, the adverse reaction rate was 0.28% — not significantly different (p=.69) from the reaction rate of 0.43% among 3,933 patients (1,992 men, 1,941 women; median age, 48.6 years) who received iohexol 350 maintained at room temperature. Furthermore, the risk difference in the body temperature group for adverse reactions relative to the room temperature group was below the non-inferiority margin of 0.6%.  

Acknowledging that their results do not include the impact of extrinsic warming on other endpoints (i.e., image quality, patient comfort, etc.), “our findings question the utility of prewarming contrast media, which can be a resource-intensive process,” the authors of this AJR article maintained.

For more information: www.arrs.org

Related Content

News | X-Ray

August 17, 2022 — The Institute of Human Virology in Nigeria (IHVN) has announced their partnership with Fujifilm, the ...

Time August 17, 2022
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

Did you know that Imaging Technology News (ITN) maintains more than 40 comparison charts of product specifications from ...

Time August 12, 2022
arrow
News | Radiology Education

August 11, 2022 — After a three-year break, this spring featured the return of the anticipated Canon Roadshow Events ...

Time August 11, 2022
arrow
News | Computed Tomography (CT)

August 11, 2022 — For the first time, researchers successfully captured CT images of an entire woolly mammoth tusk ...

Time August 11, 2022
arrow
News | Radiology Imaging

August 11, 2022 — Bracco Imaging S.p.A. has announced the renewal of the “Bracco Fellowships” initiative, in partnership ...

Time August 11, 2022
arrow
News | Ultrasound Imaging

August 10, 2022 — Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body ...

Time August 10, 2022
arrow
News | Point-of-Care Ultrasound (POCUS)

August 10, 2022 — Mindray North America, a global leader and developer of healthcare technologies and solutions for ...

Time August 10, 2022
arrow
News | Lung Imaging

August 8, 2022 — Representatives from the Diagnostics Working Group of the IASLC Early Detection and Screening Committee ...

Time August 08, 2022
arrow
News | X-Ray

August 5, 2022 — GE Healthcare released its most advanced fixed X-ray system yet, the next-generation Definium 656 HD ...

Time August 05, 2022
arrow
News | Computed Tomography (CT)

August 4, 2022 — Xoran Technologies announces that last month it received FDA 510(k) clearance for TRON — a truly mobile ...

Time August 04, 2022
arrow
Subscribe Now